• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MicroRNA-199b 通过自动扩增环靶向核激酶 Dyrk1a,促进钙调磷酸酶/NFAT 信号传导。

MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.

机构信息

Hubrecht Institute, Royal Netherlands Academy of Sciences, PO Box 85164, Utrecht, The Netherlands.

出版信息

Nat Cell Biol. 2010 Dec;12(12):1220-7. doi: 10.1038/ncb2126. Epub 2010 Nov 21.

DOI:10.1038/ncb2126
PMID:21102440
Abstract

MicroRNAs (miRs) are a class of single-stranded, non-coding RNAs of about 22 nucleotides in length. Increasing evidence implicates miRs in myocardial disease processes. Here we show that miR-199b is a direct calcineurin/NFAT target gene that increases in expression in mouse and human heart failure, and targets the nuclear NFAT kinase dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a (Dyrk1a), constituting a pathogenic feed forward mechanism that affects calcineurin-responsive gene expression. Mutant mice overexpressing miR-199b, or haploinsufficient for Dyrk1a, are sensitized to calcineurin/NFAT signalling or pressure overload and show stress-induced cardiomegaly through reduced Dyrk1a expression. In vivo inhibition of miR-199b by a specific antagomir normalized Dyrk1a expression, reduced nuclear NFAT activity and caused marked inhibition and even reversal of hypertrophy and fibrosis in mouse models of heart failure. Our results reveal that microRNAs affect cardiac cellular signalling and gene expression, and implicate miR-199b as a therapeutic target in heart failure.

摘要

MicroRNAs (miRs) 是一类约 22 个核苷酸长的单链非编码 RNA。越来越多的证据表明,miRs 参与了心肌疾病的发生发展过程。在这里,我们发现 miR-199b 是钙调神经磷酸酶/NFAT 的直接靶基因,在小鼠和人类心力衰竭中表达增加,并靶向核 NFAT 激酶双特异性酪氨酸-(Y)-磷酸化调节激酶 1a(Dyrk1a),构成影响钙调神经磷酸酶反应性基因表达的致病正反馈机制。过表达 miR-199b 的突变小鼠或 Dyrk1a 杂合不足的小鼠对钙调神经磷酸酶/NFAT 信号或压力超负荷更为敏感,并通过减少 Dyrk1a 表达表现出应激诱导的心脏增大。通过特异性反义核苷酸抑制体内 miR-199b,可使 Dyrk1a 的表达正常化,降低核 NFAT 活性,并显著抑制甚至逆转心力衰竭小鼠模型中的肥大和纤维化。我们的研究结果表明,miRNAs 影响心脏细胞的信号转导和基因表达,并提示 miR-199b 是心力衰竭的治疗靶点。

相似文献

1
MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.MicroRNA-199b 通过自动扩增环靶向核激酶 Dyrk1a,促进钙调磷酸酶/NFAT 信号传导。
Nat Cell Biol. 2010 Dec;12(12):1220-7. doi: 10.1038/ncb2126. Epub 2010 Nov 21.
2
Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.心肌细胞中 DYRK1A 的过度表达抑制了急性 NFAT 的激活,但不能预防体内的心肌肥厚。
Cardiovasc Res. 2011 Jun 1;90(3):521-8. doi: 10.1093/cvr/cvr023. Epub 2011 Jan 27.
3
Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.Dyrk1a 通过 D 型细胞周期蛋白依赖性 Rb/E2f 信号通路调节心肌细胞周期。
Cardiovasc Res. 2016 Jun 1;110(3):381-94. doi: 10.1093/cvr/cvw074. Epub 2016 Apr 7.
4
DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy.双重特异性酪氨酸磷酸化调节激酶1A(DYRK1A)是心肌细胞肥大的新型负调控因子。
J Biol Chem. 2009 Jun 19;284(25):17320-17327. doi: 10.1074/jbc.M109.006759. Epub 2009 Apr 16.
5
NGF upregulates the plasminogen activation inhibitor-1 in neurons via the calcineurin/NFAT pathway and the Down syndrome-related proteins DYRK1A and RCAN1 attenuate this effect.神经生长因子通过钙调神经磷酸酶/NFAT 途径上调神经元中的纤溶酶原激活抑制剂-1,而与唐氏综合征相关的蛋白 DYRK1A 和 RCAN1 则减弱这种作用。
PLoS One. 2013 Jun 25;8(6):e67470. doi: 10.1371/journal.pone.0067470. Print 2013.
6
Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.RCAN1 蛋白活性的调节由 Dyrk1A 蛋白介导的磷酸化作用。
J Biol Chem. 2011 Nov 18;286(46):40401-12. doi: 10.1074/jbc.M111.253971. Epub 2011 Sep 30.
7
Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.有氧运动训练对心力衰竭小鼠的心脏抗重构作用与钙调神经磷酸酶/活化T细胞核因子信号通路的降低有关。
J Physiol. 2009 Aug 1;587(Pt 15):3899-910. doi: 10.1113/jphysiol.2009.173948. Epub 2009 Jun 8.
8
Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.钙调神经磷酸酶/活化T细胞核因子偶联参与病理性而非生理性心肌肥大。
Circ Res. 2004 Jan 9;94(1):110-8. doi: 10.1161/01.RES.0000109415.17511.18. Epub 2003 Dec 1.
9
TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.在病理性心脏重塑过程中,瞬时受体电位阳离子通道蛋白6(TRPC6)构成了一个钙调神经磷酸酶信号通路。
J Clin Invest. 2006 Dec;116(12):3114-26. doi: 10.1172/JCI27702. Epub 2006 Nov 9.
10
A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT.一项全基因组的果蝇RNA干扰筛选将双特异性酪氨酸磷酸化调节激酶(DYRK)家族激酶鉴定为活化T细胞核因子(NFAT)的调节因子。
Nature. 2006 Jun 1;441(7093):646-50. doi: 10.1038/nature04631. Epub 2006 Mar 1.

引用本文的文献

1
Myocardial phosphoproteomics unveils a key role of DYRK1A in aortic valve replacement-induced reverse remodelling.心肌磷酸化蛋白质组学揭示了DYRK1A在主动脉瓣置换诱导的逆向重塑中的关键作用。
Basic Res Cardiol. 2025 Jul 6. doi: 10.1007/s00395-025-01125-w.
2
Obesity and Heart Failure: Mechanistic Insights and the Regulatory Role of MicroRNAs.肥胖与心力衰竭:机制洞察及微小RNA的调节作用
Genes (Basel). 2025 May 28;16(6):647. doi: 10.3390/genes16060647.
3
Unlocking the Therapeutic Potential of the Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitors in Alzheimer's Diseases.

本文引用的文献

1
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts.微小 RNA-133a 可预防心肌纤维化并调节电复极化,而不影响压力超负荷成年心脏的肥厚。
Circ Res. 2010 Jan 8;106(1):166-75. doi: 10.1161/CIRCRESAHA.109.202176. Epub 2009 Nov 5.
2
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.微小RNA-92a调控小鼠缺血组织的血管生成和功能恢复。
Science. 2009 Jun 26;324(5935):1710-3. doi: 10.1126/science.1174381. Epub 2009 May 21.
3
DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy.
揭示双特异性酪氨酸磷酸化调节激酶1A抑制剂在阿尔茨海默病中的治疗潜力
Mol Neurobiol. 2025 Mar 5. doi: 10.1007/s12035-025-04806-8.
4
Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.抑制钙调神经磷酸酶可能预防唐氏综合征患者患阿尔茨海默病。
Alzheimers Dement. 2025 Mar;21(3):e70034. doi: 10.1002/alz.70034.
5
Overexpression of miR-199b-5p in Colony Forming Unit-Hill's Colonies Positively Mediates the Inflammatory Response in Subclinical Cardiovascular Disease Model: Metformin Therapy Attenuates Its Expression.miR-199b-5p 在集落形成单位-希尔斯集落中的过表达正向介导亚临床心血管疾病模型中的炎症反应:二甲双胍治疗可减弱其表达。
Int J Mol Sci. 2024 Jul 25;25(15):8087. doi: 10.3390/ijms25158087.
6
An RNA-seq study in Friedreich ataxia patients identified hsa-miR-148a-3p as a putative prognostic biomarker of the disease.一项在弗里德里希共济失调患者中的 RNA-seq 研究发现,hsa-miR-148a-3p 可作为该疾病的潜在预后生物标志物。
Hum Genomics. 2024 May 22;18(1):50. doi: 10.1186/s40246-024-00602-y.
7
Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review.非编码 RNA 靶向治疗:最新综述。
Int J Mol Sci. 2024 Mar 24;25(7):3630. doi: 10.3390/ijms25073630.
8
Differentially expressed miR-127, miR-150, and miR-145 in serum extracellular vesicles are novel diagnostic biomarkers of unstable angina.血清细胞外囊泡中差异表达的miR-127、miR-150和miR-145是不稳定型心绞痛的新型诊断生物标志物。
Cardiovasc Diagn Ther. 2023 Oct 31;13(5):866-878. doi: 10.21037/cdt-22-575. Epub 2023 Aug 29.
9
The Roles of microRNAs in the Cardiovascular System.microRNAs 在心血管系统中的作用。
Int J Mol Sci. 2023 Sep 19;24(18):14277. doi: 10.3390/ijms241814277.
10
New insights into the roles for DYRK family in mammalian development and congenital diseases.DYRK家族在哺乳动物发育和先天性疾病中作用的新见解。
Genes Dis. 2022 Jan 6;10(3):758-770. doi: 10.1016/j.gendis.2021.12.004. eCollection 2023 May.
双重特异性酪氨酸磷酸化调节激酶1A(DYRK1A)是心肌细胞肥大的新型负调控因子。
J Biol Chem. 2009 Jun 19;284(25):17320-17327. doi: 10.1074/jbc.M109.006759. Epub 2009 Apr 16.
4
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.微小RNA-21通过刺激成纤维细胞中的丝裂原活化蛋白激酶信号传导,导致心肌疾病。
Nature. 2008 Dec 18;456(7224):980-4. doi: 10.1038/nature07511. Epub 2008 Nov 30.
5
microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart.微小RNA-133a调节心肌细胞增殖并抑制心脏中平滑肌基因的表达。
Genes Dev. 2008 Dec 1;22(23):3242-54. doi: 10.1101/gad.1738708. Epub 2008 Nov 17.
6
Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling.出生后心肌中条件性Dicer基因缺失会引发自发性心脏重塑。
Circulation. 2008 Oct 7;118(15):1567-76. doi: 10.1161/CIRCULATIONAHA.108.769984. Epub 2008 Sep 22.
7
NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure.NFATc2是钙调神经磷酸酶依赖性心脏肥大和心力衰竭的必要介质。
J Biol Chem. 2008 Aug 8;283(32):22295-303. doi: 10.1074/jbc.M801296200. Epub 2008 May 12.
8
Cholecystokinin activates pancreatic calcineurin-NFAT signaling in vitro and in vivo.胆囊收缩素在体外和体内均可激活胰腺钙调神经磷酸酶-NFAT信号通路。
Mol Biol Cell. 2008 Jan;19(1):198-206. doi: 10.1091/mbc.e07-05-0430. Epub 2007 Oct 31.
9
MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure.人类心脏中的微小RNA:心力衰竭中胎儿基因重编程的线索
Circulation. 2007 Jul 17;116(3):258-67. doi: 10.1161/CIRCULATIONAHA.107.687947. Epub 2007 Jul 2.
10
MicroRNA-133 controls cardiac hypertrophy.微小RNA-133调控心肌肥大。
Nat Med. 2007 May;13(5):613-8. doi: 10.1038/nm1582. Epub 2007 Apr 29.